サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1354619

先進治療薬の世界市場

Advanced Therapy Medicinal Products
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 436 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
先進治療薬の世界市場
出版日: 2023年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 436 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

先進治療薬の世界市場は2030年までに240億米ドルに達する

2022年に97億米ドルと推定された先進治療薬の世界市場は、2022年から2030年にかけて12%のCAGRで成長し、2030年には240億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである組織工学製品は、CAGR 12.7%を記録し、分析期間終了時には100億米ドルに達すると予測されます。細胞療法分野の成長は、今後8年間のCAGRが11.3％と推定されています。

米国市場は43億米ドルと推定、中国はCAGR 10.4％で成長予測

米国の先進治療薬市場は、2022年には43億米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年のCAGR10.4%で、2030年までに11億米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ10%と8.9%の成長が予測されています。欧州では、ドイツがCAGR約13.1%で成長すると予測されています。

調査対象企業の例

  • Bluebird Bio Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • JCR Pharmaceuticals Co. Ltd.
  • Kolon TissueGene, Inc.
  • MEDIPOST Co., Ltd.
  • Novartis AG
  • Organogenesis Inc.
  • Spark Therapeutics, Inc.
  • UniQure N.V.
  • Vericel Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP21058

What`s New?

» Special discussions on the global economic climate and market sentiment

» Coverage on global competitiveness and key competitor percentage market shares

» Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial

» Online interactive peer-to-peer collaborative bespoke updates

» Access to our digital archives and MarketGlass™ research platform

» Complimentary updates for one year

» Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

Economic Outlook

The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US$6 trillion economy by 2030, surpassing Japan and Germany.

The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Advanced Therapy Medicinal Products Market to Reach $24 Billion by 2030

The global market for Advanced Therapy Medicinal Products estimated at US$9.7 Billion in the year 2022, is projected to reach a revised size of US$24 Billion by 2030, growing at a CAGR of 12% over the period 2022-2030. Tissue Engineered Products, one of the segments analyzed in the report, is projected to record 12.7% CAGR and reach US$10 Billion by the end of the analysis period. Growth in the Cell Therapy segment is estimated at 11.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.3 Billion, While China is Forecast to Grow at 10.4% CAGR

The Advanced Therapy Medicinal Products market in the U.S. is estimated at US$4.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 10.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10% and 8.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.1% CAGR.

Select Competitors (Total 190 Featured) -

  • Bluebird Bio Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • JCR Pharmaceuticals Co. Ltd.
  • Kolon TissueGene, Inc.
  • MEDIPOST Co., Ltd.
  • Novartis AG
  • Organogenesis Inc.
  • Spark Therapeutics, Inc.
  • UniQure N.V.
  • Vericel Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • A Prelude to Advanced Therapy Medicinal Products (ATMP)
    • ATMPs' Costs and Availability
    • Impact of Covid-19 and a Looming Global Recession
    • From Pandemic to War & Inflation: "Gloomy Outlook for 2023 Despite Signs of Easing Inflationary Conditions
    • Here's How Inflationary Pressures Affect the Economy
    • Although Past Peak in 2023, Efforts to Solve the Inflation Puzzle Should Continue
    • Here's What's Causing Inflationary Pressures in the Global Market
    • Shaken by the War, Global Oil Prices Spiral and Feed Inflationary Pressures, Guiding the World Towards a Cost of Living Crisis: Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2017 through 2024
    • War-Induced Commodity Price Increases & Broad Based Price Pressures Mark the Return of Global Inflation to the Highest Level Seen Since 1996: Global Inflation Rates (In %) for the Years 2019 Through 2024
    • Although Facing a Lower Recession Risk, Global Economic Growth in 2023 to Slowdown Amid War, Inflation, Elevated Interest Rates & Marginal Easing of Inflation: World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2020 Through 2024
    • Recession Triggered by Uncontrolled Inflation or Unemployment, Which is the Greater Evil? Inflation Battling Policy Measures to Slowdown Post Pandemic Recovery in Unemployment Rates: Global Number of Unemployed People (In Million) for Years 2019 Through 2024
    • Global Market Prospects and Outlook
    • Advanced Therapy Medicinal Products Market Poised to Witness Rapid Growth
    • Growth Drivers and Challenges
    • ATMP Marketing Authorisations: An Insight
    • ATMP Marketing Approvals in the US: 2021-2023
    • ATMP Marketing Approvals in Europe: 2020-2022
    • North America and Europe Dominate, Asia-Pacific to Exhibit Fastest Growth
    • Competition
    • Recent Market Activity
    • Advanced Therapy Medicinal Products - Global Key Competitors Percentage Market Share in 2023 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Geriatric Population and Subsequent Growth in Prevalence of Neurological Disorders Drive Market Demand
    • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Regenerative Medicine: A Promising Area for Advanced Therapy Medicinal Products
    • Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
    • Global Regenerative Medicines Market by Category: Breakdown (in %) for Biomaterials, Stem Cell Therapies and Tissue Engineering for 2022
    • Stem Cell Therapy: A Promising Avenue for Nerve Repair and Regeneration
    • Rising Demand for Gene Therapy Spurs Market Expansion
    • List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
    • Top Ten Genetic Diseases Worldwide
    • Oncology Represents the Largest Indication for Gene Therapy
    • Breakdown of Total Number of Cancer Cases by Region: 2020
    • Breakdown of Total Number of Cancer Cases by Type: 2020
    • Uptrend in Healthcare Spending Creates Fertile Environment
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Expanding Role of Advanced Therapy Medicinal Products Market in Personalized Medicine
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
    • World Personalized Medicine Market by Region/Country (2022): Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific and Rest of World
    • Biotech Research Spending Patterns Steer Momentum
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Advanced Therapy Medicinal Products Market Analysis of Annual Sales in US$ Million for Years 2022 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 3: World 8-Year Perspective for Advanced Therapy Medicinal Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Tissue Engineered Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World 8-Year Perspective for Tissue Engineered Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 7: World 8-Year Perspective for Cell Therapy by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 9: World 8-Year Perspective for Gene Therapy by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for CAR-T Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World 8-Year Perspective for CAR-T Therapy by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 12: USA Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 13: USA 8-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2023 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 15: Canada 8-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2023 & 2030
  • JAPAN
    • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 16: Japan Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 17: Japan 8-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2023 & 2030
  • CHINA
    • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 18: China Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 19: China 8-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2023 & 2030
  • EUROPE
    • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 20: Europe Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 21: Europe 8-Year Perspective for Advanced Therapy Medicinal Products by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 22: Europe Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 23: Europe 8-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2023 & 2030
  • FRANCE
    • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 24: France Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 25: France 8-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2023 & 2030
  • GERMANY
    • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 26: Germany Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Germany 8-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2023 & 2030
  • ITALY
    • TABLE 28: Italy Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Italy 8-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2023 & 2030
  • UNITED KINGDOM
    • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 30: UK Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 31: UK 8-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 32: Rest of Europe Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Rest of Europe 8-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 34: Asia-Pacific Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Asia-Pacific 8-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 36: Rest of World Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Rest of World 8-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2023 & 2030

IV. COMPETITION